APA (7th ed.) Citation

Tony A. Koehn, Lori L. Scardino, Kory L. Alderson, Amy K. Erbe, Kim A. McDowell, Bartosz eGrzywacz, . . . Paul Mark Sondel. (2012). Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: Potential predictors of successful clinical outcome observed in high-risk neuroblastoma. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Tony A. Koehn, Lori L. Scardino, Kory L. Alderson, Amy K. Erbe, Kim A. McDowell, Bartosz eGrzywacz, Jacquelyn A. Hank, and Paul Mark Sondel. Increasing the Clinical Efficacy of NK and Antibody-mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Observed in High-risk Neuroblastoma. Frontiers Media S.A., 2012.

MLA (9th ed.) Citation

Tony A. Koehn, et al. Increasing the Clinical Efficacy of NK and Antibody-mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Observed in High-risk Neuroblastoma. Frontiers Media S.A., 2012.